What is PhytogenX?
Based in Morgantown, Pennsylvania, PhytogenX operates as a specialized contract manufacturer for the skincare industry. The company maintains a robust 110,000-square-foot facility that holds critical certifications, including FDA compliance and medical device manufacturing standards. With a dedicated laboratory staffed by nine expert chemists, PhytogenX provides comprehensive services ranging from product formulation and improvement to complex reverse-engineering. By prioritizing safety and quality, the firm has positioned itself as a vital partner for brands seeking to navigate the technical complexities of OTC and medical-grade skincare production.
How much funding has PhytogenX raised?
PhytogenX has raised a total of $2.2M across 2 funding rounds:
Debt
$1M
Debt
$1.2M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.2M led by PPP
Key Investors in PhytogenX
PPP
Public-Private Partnership
What's next for PhytogenX?
With this recent capital, PhytogenX is well-positioned to accelerate its growth trajectory within the competitive contract manufacturing landscape. The strategic allocation of these funds will likely focus on enhancing laboratory throughput and optimizing supply chain efficiencies to meet the rising demand for high-quality, certified skincare products. As the company continues to leverage its technical expertise, it is expected to expand its footprint in the medical device and OTC sectors, solidifying its reputation as a reliable enterprise-level manufacturing partner. Future initiatives will likely center on technological upgrades to its Morgantown facility to maintain its competitive edge in product innovation and regulatory compliance.
See full PhytogenX company page
